| Atropisomerism in medicinal chemistry: challenges and opportunities |
30 |
| Anticancer metallodrugs: where is the next cisplatin? |
26 |
| Deep learning for molecular generation |
21 |
| Carbonic anhydrase activators |
20 |
| PAAP: a web server for predicting antihypertensive activity of peptides |
16 |
| Translational role of natural coumarins and their derivatives as anticancer agents |
14 |
| Deep learning and virtual drug screening |
13 |
| Thiazole in the targeted anticancer drug discovery |
13 |
| Mn(II) compounds as an alternative to Gd-based MRI probes |
13 |
| Metal-based antitumor compounds: beyond cisplatin |
13 |
| Antimicrobial activity of 4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus |
12 |
| Antischistosomal agents: state of art and perspectives |
11 |
| A survey of the role of nitrile groups in protein-ligand interactions |
11 |
| Diverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activity |
11 |
| Discovery of arginine-containing tripeptides as a new class of pancreatic lipase inhibitors |
10 |
| Use of Simplified Molecular Input Line Entry System and molecular graph based descriptors in prediction and design of pancreatic lipase inhibitors |
9 |
| Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy |
9 |
| Gadolinium as an MRI contrast agent |
9 |
| Suramin potently inhibits cGAMP synthase, cGAS, in THP1 cells to modulate IFN-beta levels |
9 |
| Hypoxia-inducible factor 2 alpha: a novel target in gliomas |
9 |
| Recent advances of thiazole hybrids in biological applications |
9 |
| Recent progress in the discovery and development of DNA gyrase B inhibitors |
9 |
| Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease |
9 |
| An efficient formulation based on cationic porphyrins to photoinactivate Staphylococcus aureus and Escherichia coli |
9 |
| Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier |
9 |
| The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio-and nephroprotection |
8 |
| Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights |
8 |
| Benzodifurans for biomedical applications: BZ a selective anti-proliferative and anti-amyloid lead compound |
8 |
| Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents |
8 |
| Exosome manufacturing status |
8 |
| Rational application of drug promiscuity in medicinal chemistry |
8 |
| Immunological axis of curcumin-loaded vesicular drug delivery systems |
8 |
| Recent advances in inhibitors of sirtuin1/2: an update and perspective |
8 |
| The polypharmacology of natural products |
8 |
| The specific role of O-6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy |
8 |
| Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations |
8 |
| Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications |
7 |
| Pyrrolo[1-a]isoquinoline scaffold in drug discovery: advances in synthesis and medicinal chemistry |
7 |
| Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters |
7 |
| Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity |
7 |
| Recent advances in CDK inhibitors for cancer therapy |
7 |
| Amyloid beta-targeted metal complexes for potential applications in Alzheimer's disease |
7 |
| Cancer-targeted delivery systems based on peptides |
7 |
| Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery |
7 |
| Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives |
7 |
| Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemoprevention |
7 |
| Novel 4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis |
7 |
| Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies |
7 |
| Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria |
7 |
| A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data |
7 |
